Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Altered fractionation in radiotherapy

R Valdagni1

  • 1Division of Radiation Oncology, Casa di Cura S. Pio X, Milan, Italy. equipert.spiox@interbusiness.it

Tumori
|June 10, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2021
Same author

What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study.

Prostate cancer and prostatic diseases·2021
Same author

Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?

Journal of cancer research and clinical oncology·2020
Same author

COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractions.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Same author

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same journal

End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

Tumori·2026
Same journal

Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

Tumori·2026
Same journal

Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

Tumori·2026
Same journal

Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

Tumori·2026
Same journal

Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

Tumori·2026
Same journal

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Tumori·2026
See all related articles

Altered fractionation schemes, using multiple small radiation doses daily, aim to reduce normal tissue damage and combat tumor repopulation. Clinical trials suggest these regimens offer therapeutic benefits in cancer treatment.

Area of Science:

  • Radiation Oncology
  • Cancer Treatment
  • Radiobiology

Background:

  • Normal tissues and tumors exhibit different proliferation rates, influencing treatment response.
  • Tumor cell repopulation during therapy necessitates optimized radiation fractionation.
  • Conventional fractionation regimens lack a universal standard, with U.S. and European schedules often used as controls.

Purpose of the Study:

  • To explore the rationale and potential benefits of altered fractionation schemes in radiation therapy.
  • To investigate hyperfractionated and accelerated regimens for improved therapeutic outcomes.
  • To compare novel fractionation schedules against established conventional regimens.

Main Methods:

  • Utilizing schedules with two or more small radiation fractions per day.

Related Experiment Videos

  • Implementing interfraction intervals of at least 6 hours.
  • Comparing experimental regimens against continental European and U.S. conventional schedules in clinical trials.

    • Main Results:

    • Altered fractionation allows for higher total doses, potentially reducing late normal tissue damage.
    • Reduced overall treatment time with altered fractionation can overcome tumor cell repopulation.
    • Phase I-II and III trials indicate a therapeutic benefit from altered fractionation regimens.

    Conclusions:

    • Altered fractionation schemes represent a promising advancement in radiation oncology.
    • These regimens offer a strategy to improve the therapeutic ratio by sparing normal tissues and controlling tumor growth.
    • Clinical evidence supports the efficacy of hyperfractionated and accelerated radiation therapy.